Florham Park, N.J. & San Diego, C.A., September 20, 2021: Celularity Inc. (“Celularity”) (Nasdaq: CELU), a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic therapies, and Oncternal Therapeutics, Inc. (“Oncternal”) (Nasdaq:...
LifebankUSA, powered by Celularity Inc, and the world’s most comprehensive company for cord, placenta and tissue banking, today unveils a brand new website and announces a relocation to new headquarters...
Celularity and Oncternal Therapeutics Enter into Research Collaboration to Evaluate Targeted Placental-Derived Cellular Therapies
Lifebank Debuts New Branding & Announces Move to New Facility